| Entry |
|
|---|
| Name |
Betahistine (INN);
Vestibo (TN)
|
|---|
| Formula |
C8H12N2
|
|---|
| Exact mass |
136.1
|
|---|
| Mol weight |
136.1943
|
|---|
| Structure |
     |
|---|
| Activity |
Autacoid, histamine
|
|---|
| Remark |
|
|---|
| Target |
|
|---|
| Pathway |
hsa04020 Calcium signaling pathway
hsa04080 Neuroactive ligand-receptor interaction | |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07C ANTIVERTIGO PREPARATIONS
N07CA Antivertigo preparations
N07CA01 Betahistine
D07522 Betahistine (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
H1-receptor [HSA:3269] [KO:K04149]
Betahistine [ATC:N07CA01]
D07522 Betahistine (INN)
H3-receptor [HSA:11255] [KO:K04151]
Betahistine [ATC:N07CA01]
D07522 Betahistine (INN)
 |
|---|
| Other DBs |
CAS: 5638-76-6 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 10
1 C8x C 27.7900 -18.6200
2 C8x C 27.7900 -17.2200
3 N5x N 26.5300 -16.5200
4 C8y C 25.3400 -17.2200
5 C8x C 25.3400 -18.6200
6 C8x C 26.5300 -19.3200
7 C1b C 24.1500 -16.5200
8 C1b C 22.8900 -17.2200
9 N1b N 21.7000 -16.5200
10 C1a C 20.5100 -17.2200
BOND 10
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 6 1 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
|
|---|
